Mission Statement

Founded in 2017, Source Research Foundation (SRF) is a 501(c)(3) non-profit research and educational organization that aims to connect, inspire, and support students who study the epidemiology, phenomenology, and the environmental, cultural and clinical contexts of psychedelic use, and to develop a virtual collaboratory of students, scientists, and community members who are passionate about psychedelic science.

We fully support and adhere to the Statement on Open Science for Psychedelic Medicines and Practices.

2019 Grant Recipients

Ana Flecha

Ana Flecha is a PhD student in Latinx studies at the University of California, Santa Cruz. Ana’s study focuses on the practice of the bailado, or the Santo Daime danced spiritual work, during a historic festival in the village Ceu do Mapiá in the Southern Amazon forest that will bring together more than a thousand Daime practitioners from various countries around the world. By focusing on the corporeal psychedelic practice of the bailado during this momentous festival, this study will consider the entanglement of gendered social roles, especially women’s leadership, within local, distant, and extended Daime communities.

Madeline Pantoni

Madeline Pantoni is a PhD student in psychology at the University of California, San Diego. Madeline’s study examines the effects of MDMA on learning and memory, social behavior, depression, and anxiety in mice across a wide range of doses. This research will greatly enhance our understanding of the therapeutic potential of MDMA, elucidate the role of dose in the behavioral effects of MDMA, and ultimately help guide future clinical studies exploring MDMA as a therapeutic for a range of psychiatric disorders.

Halsey Niles

Halsey Niles is a medical student at Yale University. He is undertaking a qualitative approach to determine major themes in the attitudes toward psychedelic-assisted therapy held by providers who care for patients facing existential distress. Analysis of themes from interviews with twenty physicians, chaplains, mental health clinicians and advanced practice providers in the fields of hospice and palliative care will provide insight into barriers to access and sources of concern for clinicians. This study will reveal avenues to increase access to psychedelic-assisted therapy for diverse patient populations.

Terence Ching

Terence Ching is a PhD student in clinical psychology at the University of Connecticut. His project aims to examine ethnic differences in efficacy, safety, and putative mechanisms of action of MDMA-assisted psychotherapy in a sample of 37 participants (27 non-Hispanic Whites, 10 participants of color) from the MAPS MP-16/17 trial. Next, this study will include an informative and destigmatizing mixed-methods case study of a participant of color who successfully completed the trial.

Dr. Giancarlo Glick

Dr. Giancarlo Glick is a psychiatry resident at Stanford University. Giancarlo’s study examines the immune-modulating effects of psychedelic-assisted therapy at the level of gene expression in patients being treated for mental illness. A secondary purpose is to examine the relationship between changes in perceived meaning and connection (eudaimonia) and the downregulation of pro-inflammatory genes.